Pharmaceutical Executive

Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here

Web Version | Share with a colleague | View Digital Edition | Subscribe

In our March issue of Pharmaceutical Executive
FEATURES

Cover Feature
Following the Science: AZ’s Habib Bennaceur
Julian Upton
AstraZeneca’s Habib Bennaceur talks about his key career transitions and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.
Download the digital issue

Multichannel Marketing
Balancing the Local and Global Voice
Julian Upton
Exploring the challenge for pharma in adapting multichannel marketing strategies for the global stage, while trying to refine messages and communicate a brand identity to multiple local audiences.
Download the digital issue

Integrating Omnichannel
Elaine Quilici
How to capitalize on the rise of omnichannel engagement in pharma and pursue myriad modes of message delivery in today’s digital world.
Download the digital issue

Market Access
From Being to Becoming
BCG Market Access Roundtable Working Group
Examining the key learnings from BCG’s 2019 benchmark study—and the capabilities uncovered that will be critical to future performance.
Download the digital issue

ALSO IN THIS ISSUE
Consider Data Before It’s a Problem
Lisa Henderson
Amid concerns over a potential "wild west" climate for data analytics in pharma, taking a long-term, proactive, and enterprise view of your company’s data may be the best way to keep your organization and reputation safe …Read more

Feds Target Biosimilar Anticompetitive Practices
Jill Wechsler
Initiatives aim to limit the gamesmanship that can inhibit prescribing of follow-on biologics …Read more

Social Media’s Influence in Messaging Mix
Miranda Schmalfuhs
A look at the ongoing barriers and opportunities in building connections between HCPs, patients, and pharma through social media …Read more

Download the
issue:

WEBCASTS

Market Pricing Dynamics for the Machine Learning Age - Are You Getting the Insights You Need?

Virtual, Decentralized, Site-less Trials… What Does it All Mean?

The Current and Future Impact of Artificial Intelligence (AI) on Pharmacovigilance

The 5 Safes of Risk-Based Anonymization

Break Free from Forecast Inaccuracy: How Machine Learning Can Drive Better Quality Commercial Forecasting

Three Key Critical Considerations Before Embarking on Decentralized Trials

Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.